Postpartum Psychiatric Disorders

In Brief: Mothers with Affective Illness (Even In Remission) Have Deficits in Emotional Processing

We have long known that postpartum depression may have negative effects on the child and may contribute to deficits in social development and emotional regulation.  Exactly what mediates these effects is not so clear; however, [...]

In Brief: ACOG Recommends Increased Level of Care During the “Fourth Trimester”

The American College of Obstetricians and Gynecologists (ACOG) has made a significant change to its recommendations for optimal postpartum care.  Previously, ACOG has recommended that women receive a single, comprehensive postpartum visit within the first [...]

One in Four Pregnant Women Suffers from Psychiatric Illness: How Can We Identify and Support Them?

  The title of the following article did not grab my attention; however, I discovered that this study, entitled Accuracy of the Whooley questions and the Edinburgh Postnatal Depression Scale in identifying depression and other [...]

Announcing the MGH Perinatal Depression Scale (MGHPDS) Mobile App Now Available for Android

  Following the release of the MGH Perinatal Depression Scale (MGHPDS) on the App Store this past August, we are pleased to announce that the MGHPDS is now available for Android devices on the Google [...]

History of Stillbirth Increases Risk for Depression, Anxiety During Subsequent Pregnancies

Perinatal loss is a traumatic event for women and their families.  While we clearly understand the potential for perinatal loss to cause significant emotional consequences, we have relatively little data on the prevalence of anxiety [...]

Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression.  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially under [...]